Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Total Current Liabilities (2016 - 2025)

Utah Medical Products has reported Total Current Liabilities over the past 16 years, most recently at $2.6 million for Q4 2025.

  • Quarterly results put Total Current Liabilities at $2.6 million for Q4 2025, down 30.85% from a year ago — trailing twelve months through Dec 2025 was $2.6 million (down 30.85% YoY), and the annual figure for FY2025 was $2.6 million, down 30.85%.
  • Total Current Liabilities for Q4 2025 was $2.6 million at Utah Medical Products, down from $3.0 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for UTMD hit a ceiling of $6.3 million in Q3 2022 and a floor of $2.3 million in Q2 2025.
  • Median Total Current Liabilities over the past 5 years was $4.4 million (2021), compared with a mean of $4.5 million.
  • Biggest five-year swings in Total Current Liabilities: soared 59.15% in 2022 and later tumbled 42.78% in 2025.
  • Utah Medical Products' Total Current Liabilities stood at $3.7 million in 2021, then soared by 59.15% to $6.0 million in 2022, then fell by 20.97% to $4.7 million in 2023, then decreased by 20.23% to $3.8 million in 2024, then plummeted by 30.85% to $2.6 million in 2025.
  • The last three reported values for Total Current Liabilities were $2.6 million (Q4 2025), $3.0 million (Q3 2025), and $2.3 million (Q2 2025) per Business Quant data.